BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 33968884)

  • 1. Strategies to Address COVID-19 Vaccine Hesitancy and Mitigate Health Disparities in Minority Populations.
    Strully KW; Harrison TM; Pardo TA; Carleo-Evangelist J
    Front Public Health; 2021; 9():645268. PubMed ID: 33968884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No Populations Left Behind: Vaccine Hesitancy and Equitable Diffusion of Effective COVID-19 Vaccines.
    Webb Hooper M; Nápoles AM; Pérez-Stable EJ
    J Gen Intern Med; 2021 Jul; 36(7):2130-2133. PubMed ID: 33754319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and social science in support of SARS-CoV-2 vaccination: National Institutes of Health initiatives.
    Hunter CM; Chou WS; Webb Hooper M
    Transl Behav Med; 2021 Jul; 11(7):1354-1358. PubMed ID: 34080616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies.
    Hussain B; Latif A; Timmons S; Nkhoma K; Nellums LB
    Vaccine; 2022 May; 40(25):3413-3432. PubMed ID: 35534309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring COVID-19 Vaccine Attitudes among Racially and Ethnically Minoritized Communities: Community Partners' and Residents' Perspectives.
    Martinez Leal I; Njoh J; Chen TA; Foreman-Hays F; Reed BC; Haley SA; Chavez K; Reitzel LR; Obasi EM
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary: Strategies to Address COVID-19 Vaccine Hesitancy and Mitigate Health Disparities in Minority Populations.
    Teo J
    Front Public Health; 2021; 9():723583. PubMed ID: 34395375
    [No Abstract]   [Full Text] [Related]  

  • 7. Exploring Perspectives on Establishing COVID-19 Vaccine Confidence in Black Communities.
    Mansfield LN; Carson SL; Castellon-Lopez Y; Casillas A; Morris D; Ntekume E; Barron J; Norris KC; Brown AF
    Ethn Dis; 2022; 32(4):341-350. PubMed ID: 36388857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trust, influence, and community: Why pharmacists and pharmacies are central for addressing vaccine hesitancy.
    Shen AK; Tan ASL
    J Am Pharm Assoc (2003); 2022; 62(1):305-308. PubMed ID: 34688565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Community Determinants on Barriers and Facilitators to COVID-19 Vaccine Uptake: Regional Stakeholders' Perspectives.
    Russ S; Bennett N; van Wijngaarden E; Hill E; Liu Y
    Vaccine; 2024 Feb; 42(5):1160-1167. PubMed ID: 38272763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing barriers to access and equity for COVID-19 vaccination in the US.
    Kuehn M; LaMori J; DeMartino JK; Mesa-Frias M; Doran J; Korrapati L; Bhojwani R; Lefebvre P; Kirson N
    BMC Public Health; 2022 Dec; 22(1):2263. PubMed ID: 36463172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to COVID-19 vaccination among older adults in Mexico City.
    Gaitán-Rossi P; Mendez-Rosenzweig M; García-Alberto E; Vilar-Compte M
    Int J Equity Health; 2022 Jun; 21(1):85. PubMed ID: 35717236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building public trust: a response to COVID-19 vaccine hesitancy predicament.
    Vergara RJD; Sarmiento PJD; Lagman JDN
    J Public Health (Oxf); 2021 Jun; 43(2):e291-e292. PubMed ID: 33454769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engaging Latino Families About COVID-19 Vaccines: A Qualitative Study Conducted in Oregon, USA.
    Garcia J; Vargas N; de la Torre C; Magana Alvarez M; Clark JL
    Health Educ Behav; 2021 Dec; 48(6):747-757. PubMed ID: 34596462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd Immunity.
    Hildreth JEK; Alcendor DJ
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34064726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Arizona Prevention Research Center partnerships in Arizona to promote COVID-19 vaccine health equity.
    Nuño T; Sierra LA; Wilkinson-Lee A; Carvajal S; de Zapien J; Coulter K; Figueroa C; Morales M; Sepulveda R; Sepulveda R; Ingram M
    Front Public Health; 2022; 10():944887. PubMed ID: 35958854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial Disparities in COVID-19 Vaccine Acceptance: Building Trust to Protect Nursing Home Staff and Residents.
    Feifer RA; Bethea L; White EM
    J Am Med Dir Assoc; 2021 Sep; 22(9):1853-1855.e1. PubMed ID: 34375655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moving the needle on racial disparity: COVID-19 vaccine trust and hesitancy.
    Lin C; Tu P; Terry TC
    Vaccine; 2022 Jan; 40(1):5-8. PubMed ID: 34839990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trusted messengers and trusted messages: The role for community-based organizations in promoting COVID-19 and routine immunizations.
    Shen AK; Browne S; Srivastava T; Kornides ML; Tan ASL
    Vaccine; 2023 Mar; 41(12):1994-2002. PubMed ID: 36803894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The UPTAKE study: a cross-sectional survey examining the insights and beliefs of the UK population on COVID-19 vaccine uptake and hesitancy.
    Sethi S; Kumar A; Mandal A; Shaikh M; Hall CA; Kirk JMW; Moss P; Brookes MJ; Basu S
    BMJ Open; 2021 Jun; 11(6):e048856. PubMed ID: 34130964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing Inequities in SARS-CoV-2 Vaccine Uptake: The Boston Medical Center Health System Experience.
    Assoumou SA; Peterson A; Ginman E; James T; Pierre CM; Hamilton S; Chapman S; Goldie J; Koenig R; Mendez-Escobar E; Leaver H; Graham R; Crichlow R; Weaver T; Cotterell S; Valdez G; De Las Nueces D; Scott NA; Linas BP; Cherry PM
    Ann Intern Med; 2022 Jun; 175(6):879-884. PubMed ID: 35576586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.